Search Results for: TYRO3

September 13, 2018September 13, 2018

The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.

Publication date: Sep 12, 2018 Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system (CNS). Major deficits arise in MS patients due to an inability to ... Read more

July 9, 2019July 9, 2019

Why the absence of hope may be hurting Huntington’s disease research

Huntington's Disease News

Publication date: Jul 09, 2019 The author of those words is George Huntington, the physician credited with defining the disease that carries his name, Huntington’s Disease, a genetic, invariably fatal, ... Read more

July 4, 2019July 4, 2019

MERTK acts as a costimulatory receptor on human CD8+ T cells.

Melanoma Literature

Publication date: Jul 02, 2019 The TAM family of receptor tyrosine kinases (TYRO3, AXL, and MERTK) is known to be expressed on antigen-presenting cells and function as oncogenic drivers and ... Read more

May 12, 2019

The Right Way to Wear Sunscreen

Melanoma News

Publication date: May 12, 2019 And although genetics can certainly affect your skin cancer risk, proper use of sun protection plays a huge role in prevention. In fact, a study ... Read more

May 10, 2019May 10, 2019

Over-ground walking or robot-assisted gait training in people with .multiple sclerosis: does the effect depend on baseline walking speed and disease related disabilities? A systematic review and meta-regression.

Multiple Sclerosis Literature

Publication date: May 08, 2019 It was suggested that robot-assisted gait training (RAGT) should not be routinely provided to disabled patients in place of conventional over-ground walking training (CGT). There ... Read more

March 28, 2019March 28, 2019

Cross-talk between receptor tyrosine kinases AXL and ERBB3 regulates invadopodia formation in melanoma cells.

Melanoma Literature

Publication date: Mar 26, 2019 The invasive phenotype of metastatic cancer cells is accompanied by the formation of actin-rich invadopodia, which adhere to the extracellular matrix and degrade it. In ... Read more

March 2, 2019March 2, 2019

Why Big Pharma Is Diving Into Gene Therapy

Huntington's Disease News

Publication date: Mar 02, 2019 The latest is Roche Holding (ticker: RHHBY), which agreed this past week to pay $4. 8 billion for Spark Therapeutics (ONCE), a maker of gene ... Read more

February 9, 2019February 9, 2019

A mathematical model as a tool to identify microRNAs with highest impact on transcriptome changes.

Melanoma Literature

Publication date: Feb 06, 2019 Rapid changes in the expression of many messenger RNA (mRNA) species follow exposure of cells to ionizing radiation. One of the hypothetical mechanisms of this ... Read more

January 29, 2019January 29, 2019

Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia.

Tuberculosis Literature

Publication date: Mar 21, 2016 There is growing evidence suggesting that diabetes mellitus (DM) affects disease presentation and treatment outcome in tuberculosis (TB) patients. This study aimed at investigating the ... Read more

December 5, 2018December 5, 2018

MS Momentum – 05-12-2018 – Shirley – Mobility Solutions

Multiple Sclerosis Media

Publication date: Dec 04, 2018 Shirley – Mobility Solutions Broadcast on OAR 105.4FM Dunedin www.oar.org.nz